About Dallas Formulations
Dallas Formulations is a company based in Chandigarh (India) founded in 1998. It operates as a B2B and Ethical Marketing. The company has 22 employees as of March 31, 2024. Dallas Formulations offers products and services including Tablet Formulations, Capsule Formulations, Injectables Formulations, Derma Care Products, and Paediatric Syrups. Dallas Formulations operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Chandigarh, India
- Employees 22 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dallas Formulations Private Limited
- Date of Incorporation 24 Nov, 2000
- Jurisdiction Ujjain, Madhya Pradesh, India
-
Annual Revenue
$837.79 K (USD)-6.75as on Mar 31, 2024
-
Net Profit
$19.2 K (USD)501.87as on Mar 31, 2024
-
EBITDA
$99.01 K (USD)18.82as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
22
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dallas Formulations
Dallas Formulations offers a comprehensive portfolio of products and services, including Tablet Formulations, Capsule Formulations, Injectables Formulations, Derma Care Products, and Paediatric Syrups.
Formulates tablets for various health treatments.
Produces capsules for medical applications.
Develops injectable drugs for therapeutic use.
Offers formulations for skin and topical treatments.
Creates syrups for children's health needs.
Funding Insights of Dallas Formulations
Detailed funding history for Dallas Formulations
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dallas Formulations
Investment portfolio details for Dallas Formulations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dallas Formulations
Detailed financials for Dallas Formulations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dallas Formulations Comparisons
Peer comparison for Dallas Formulations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dallas Formulations
Dallas Formulations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Dallas Formulations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dallas Formulations
Complete news archive for Dallas Formulations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dallas Formulations
Dallas Formulations was founded in 1998.
Dallas Formulations is headquartered in Chandigarh, India.
As of Mar 31, 2024, the latest employee count at Dallas Formulations is 22.
Annual revenue of Dallas Formulations is $837.79K as on Mar 31, 2024.
Dallas Formulations Pvt. Ltd. produces a range of pharmaceutical formulations including tablets, capsules, and injectables at facilities in Baddi and Vadodara. The company focuses on ethical marketing, contract manufacturing, and quality control to serve customers across India with safe and effective drugs. It emphasizes innovative products and compliance with industry standards for purity and efficacy.
Dallas Formulations's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Dallas Formulations offers Tablet Formulations, Capsule Formulations, Injectables Formulations, Derma Care Products, and Paediatric Syrups.